Pharmacological modulation of sodium channels by riluzole: An alternative to antiexcitotoxic actions

Reviews in Contemporary Pharmacotherapy

Volumn 8, Issue 4, 1997, Pages 237-246

  Urenjak, Jutta ^a   Obrenovitch, Tihomir P ^b,c  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMIC ACID; NEUROPROTECTIVE AGENT; RILUZOLE; SODIUM CHANNEL;

DRUG CLASSIFICATION; NEUROPROTECTION; PRESYNAPTIC INHIBITION; REVIEW; SYNAPTIC TRANSMISSION;

EID: 0030705997     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Alaoui F, Pratt J, Trocherie S, Court L, Stutzmann J-M. Acute effects of irradiation on the rat brain: protection by glutamate blockade. Eur J Pharmacol 1995; 276: 55-60.
2. Appel SH. Excitotoxic neuronal cell death in amyotrophic lateral sclerosis. Trends Neurosci 1993; 16: 3-5.
3. Bausch AR, Roy G. Volume-sensitive chloride channels blocked by neuroprotective drugs in human glial cells. Glia 1996; 18: 73-77.
4. Beal MF, Hyman BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 1993; 16: 125-131.
5. Becquet D, Faudon M, Hery F. In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons. Brain Res 1990; 519: 82-88.
6. Benavides J, Camelin JC, Mitrani N et al. 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. II. Biochemical properties. Neuropharmacology 1985; 24: 1085-1092.
7. Benazzouz A, Boraud T, Dubédat P, Boireau A, Stutzmann J-M, Gross C. Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. Eur J Pharmacol 1995; 284: 299-307.
8. Benoit E, Escande D. Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflugers Arch 1991; 419: 603-609.
9. Benoit E, Escande D. Fast K channels are more sensitive to riluzole than slow K channels in myelinated nerve fibre. Pflügers Arch 1993; 422: 536-538.
10. Bensimon G, Lacomblez L, Meininger V, ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585-591.
11. Boireau A, Dubédat P, Bordier F et al. Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice. Neuroreport 1994a; 5: 2657-2660.
12. +-induced increase in striatal extracellular dopamine in rats in vivo. Neuroreport 1994b; 5: 2157-2160.
13. 2+ levels in neuronal culture. Eur J Pharmacol 1992; 219: 53-57.